Incidence of end-stage renal disease in overseas-born, compared with Australian-born, non-indigenous Australians

Nephrology

Volumn 9, Issue 4, 2004, Pages 247-252

  Stewart, John H ^a   McCredie, Margaret R E ^b   McDonald, Stephen P ^c  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

Australia; End stage renal disease; Glomerulonephritis; Healthy migrant effect; Incidence; Type 2 diabetic nephropathy

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTERY DISEASE; ARTICLE; ASIA; AUSTRALIA; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE PREDISPOSITION; EUROPE; FEMALE; FOCAL GLOMERULONEPHRITIS; GLOMERULONEPHRITIS; HUMAN; HYPERTENSION; IMMIGRANT; IMMUNOGLOBULIN A NEPHROPATHY; INCIDENCE; KIDNEY FAILURE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MIDDLE EAST; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REGISTER;

ADULT; AGED; AUSTRALIA; DIABETIC NEPHROPATHIES; EMIGRATION AND IMMIGRATION; ETHNIC GROUPS; FEMALE; GLOMERULONEPHRITIS; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED;

EID: 4844229674     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2004.00258.x     Document Type: Article

References (20)

1. Australian Bureau of Statistics. Overseas-born Australians - A statistical profile. Catalogue no. 41112.0. Canberra: Australian Bureau of Statistics, 1989.
2. Rostand SG, Kirk KA, Rutsky EA, Pate BA. Racial differences in the incidence of treatment for end-stage renal disease. N. Engl. J. Med. 1982; 306: 1276-9.
3. Pugh JA, Stern MP, Haffner SM, Eifler CW, Zapata M. Excess incidence of treatment of end-stage renal disease in Mexican Americans. Am. J. Epidemiol. 1988; 127: 135-44.
4. Roderick PJ, Raleigh VS, Hallam L, Mallick NP. The need and demand for renal replacement therapy in ethnic minorities in England. J. Epidemiol. Community Health 1996; 50: 334-9.
5. Lightstone L, Rees AJ, Tomson C, Walls J, Winnearls CG, Feehally J. High incidence of end-stage renal disease in Indo-Asians in the UK. Q. J. Med. 1995; 88: 191-5.
6. Stewart JH, McCredie MRE, McDonald SP. The incidence of treated end-stage renal disease in New Zealand Maori and Pacific Island people and in Indigenous Australians. Nephrol. Dial. Transpl. 2004; 19: 678-85.
7. dos Santos Silva I. Cancer Epidemiology: Principles and Methods. Lyon: International Agency for Research on Cancer, 1999; 57-82.
8. Breslow NE, Day NE. Statistical Methods in Cancer Research, Vol. 11. The Design and Analysis of Cohort Studies (IARC Sci. Publ no. 82). Lyon: International Agency for Research on Cancer, 1987; 48-79.
9. D'Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q. J. Med. 1987; 64: 709-27.
10. Schena FP. A retrospective analysis of the natural history of primary IgA nephropathy worldwide. Am. J. Med. 1990; 89: 209-15.
11. Shaker IK, Al-Saedi AJH, Al-Salam S, Saleem MS, Al-Shamma IA. Spectrum of glomerular disease in Iraqi patients from a single center. Saudi J. Kidney Dis. Transpl. 2002; 13: 515-19.
12. Byrne C, Vernon P. Validation of the cause of renal failure of patients in the Medicare end-stage renal disease program. Am. J. Kidney Dis. 1991; 18: 375-8.
13. Perneger TV, Brancati FL, Whelton PK, Klag MJ. Studying the causes of kidney disease in humans: A review of methodologic obstacles and possible solutions. Am. J. Kidney Dis. 1995; 25: 722-31.
14. Stengel B, Billon S, van Dijk PCW et al. Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-99. Nephrol. Dial. Transpl. 2003; 18: 1824-33.
15. Cass A, Cunningham J, Wang Z, Hoy W. Social disadvantage and variation in the incidence of end-stage renal disease in Australian capital cities. Aust. N.Z. J. Public Health 2001; 25: 322-6.
16. Strong K, Trickett P, Bhatia K. The health of overseas-born Australians, 1994-96. Aust. Health Rev. 1998; 21: 124-33.
17. Songer TJ, Zimmet PZ. Epidemiology of type 11 diabetes: An international perspective. Pharmacoeconamics 1995; 8 (Suppl. 1): 1-11.
18. Michielsen P, De Schepper P. Trends of analgesic nephropathy in two high-endemic regions with different legislation. J. Am. Soc. Nephrol. 2001; 12: 550-60.
19. Onkamo P, Väänänen S, Karvonen M, Tuomilehto J. Worldwide increase in incidence of type I diabetes - the analysis of data on published incidence trends. Diabetologia 1999; 42: 1395-403.
20. Maisonneuve P, Agodoa L, Gellert R et al. Distribution of primary renal diseases leading to end stage renal failure in three major dialysis and transplant registries: Results from an international collaborative study. Am. J. Kidney Dis. 2000; 35: 157-65.